(E/Z)-MCB-613 is a pan-steroid receptor coactivator (SRC) stimulator that enhances SRC activity in cancer cells, leading to excessive reactive oxygen species (ROS) production, resulting in cellular stress and paraptosis; it functions as a cytotoxic agent with significant implications in cancer therapy.